{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T08:10:18Z","timestamp":1727079018396},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T00:00:00Z","timestamp":1723593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T00:00:00Z","timestamp":1723593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Schmerz"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s00482-024-00820-2","type":"journal-article","created":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T13:02:32Z","timestamp":1723640552000},"page":"359-361","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Zus\u00e4tzliche Erfahrungen mit medikament\u00f6ser Therapie von Trigeminalschmerzen","Additional experience with medicinal treatment of trigeminal nerve pain"],"prefix":"10.1007","volume":"38","author":[{"given":"Wolfgang","family":"Liedtke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,14]]},"reference":[{"key":"820_CR1","unstructured":"Liedtke WB (2024) Medical Treatments for Orofacial and Trigeminally Mediated. Pain (Update and Review, Including Personal Experiences from Long-Standing Clinical Practice, in Facial Pain\u2014A 21st\u00a0Century Guide: For People with Trigeminal Neuropathic Pain, J.A.\u00a0Brown and A.B.\u00a0Ciemnecki, Editors. 2024, The Publishing Portal: Los Angeles CA)"},{"key":"820_CR2","unstructured":"Liedtke, W.B.\u00a0Medications to treat facial pain. 2024 [cited 2024 April\u00a027, 2024]; Online Seminar \/ Webinar. Available from: https:\/\/www.facepain.org\/webinars\/medication-for-facial-pain-2022-fpa-conference-video-series\/."},{"key":"820_CR3","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.wneu.2016.08.102","volume":"96","author":"K Watanabe","year":"2016","unstructured":"Watanabe\u00a0K, Tubbs\u00a0RS, Satoh\u00a0S, Zomorodi\u00a0AR, Liedtke\u00a0W, Labidi\u00a0M, Friedman\u00a0AH, Fukushima\u00a0T (2016) Isolated Deep Ear Canal Pain: Possible Role of Auricular Branch of Vagus Nerve-Case Illustrations with Cadaveric Correlation. World Neurosurg 96:293\u2013301","journal-title":"World Neurosurg"},{"issue":"1","key":"820_CR4","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3171\/2023.6.JNS231346","volume":"140","author":"TS CreveCoeur","year":"2023","unstructured":"CreveCoeur\u00a0TS, Bethamcharla\u00a0R, Gold\u00a0MS, Liedtke\u00a0WB, Sekula\u00a0RF (2023) Letter to the Editor. Potential confounding variables when assessing racial disparities in outcomes after MVD for TN. J\u00a0Neurosurg 140(1):315\u2013317","journal-title":"J Neurosurg"},{"issue":"1","key":"820_CR5","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1007\/s12264-017-0200-8","volume":"34","author":"C Moore","year":"2018","unstructured":"Moore\u00a0C, Gupta\u00a0R, Jordt\u00a0SE, Chen\u00a0Y, Liedtke\u00a0WB (2018) Regulation of Pain and Itch by TRP Channels. Neurosci Bull 34(1):120\u2013142","journal-title":"Neurosci Bull"},{"key":"820_CR6","doi-asserted-by":"crossref","unstructured":"Chen, Y., P.\u00a0Kanju, Q.\u00a0Fang, S.H. Lee, P.K.\u00a0Parekh, W. Lee, C.\u00a0Moore, D.\u00a0Brenner, R.W.t. Gereau, F.\u00a0Wang, and W.\u00a0Liedtke, TRPV4 is necessary for trigeminal irritant pain and functions as a\u00a0cellular formalin receptor. Pain, 2014. 155(12): p.\u00a02662\u201372.","DOI":"10.1016\/j.pain.2014.09.033"},{"issue":"12","key":"820_CR7","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1038\/s41593-017-0012-1","volume":"20","author":"E Rodriguez","year":"2017","unstructured":"Rodriguez\u00a0E, Sakurai\u00a0K, Xu\u00a0J, Chen\u00a0Y, Toda\u00a0K, Zhao\u00a0S, Han\u00a0BX, Ryu\u00a0D, Yin\u00a0H, Liedtke\u00a0W, Wang\u00a0F (2017) A\u00a0craniofacial-specific monosynaptic circuit enables heightened affective pain. Nat Neurosci 20(12):1734\u20131743","journal-title":"Nat Neurosci"},{"issue":"1","key":"820_CR8","doi-asserted-by":"publisher","first-page":"6208","DOI":"10.1038\/s41467-021-26270-3","volume":"12","author":"M Yeo","year":"2021","unstructured":"Yeo\u00a0M, Chen\u00a0Y, Jiang\u00a0C, Chen\u00a0G, Wang\u00a0K, Chandra\u00a0S, Bortsov\u00a0A, Lioudyno\u00a0M, Zeng\u00a0Q, Wang\u00a0P, Wang\u00a0Z, Busciglio\u00a0J, Ji\u00a0RR, Liedtke\u00a0W (2021) Repurposing cancer drugs identifies kenpaullone which ameliorates pathologic pain in preclinical models via normalization of inhibitory neurotransmission. Nat Commun 12(1):6208","journal-title":"Nat Commun"},{"issue":"1","key":"820_CR9","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1124\/jpet.107.133413","volume":"326","author":"PL Sheets","year":"2008","unstructured":"Sheets\u00a0PL, Heers\u00a0C, Stoehr\u00a0T, Cummins\u00a0TR (2008) Differential block of sensory neuronal voltage-gated sodium channels by lacosamide [(2R)-2-(acetylamino)-N-benzyl-3-methoxypropanamide], lidocaine, and carbamazepine. J\u00a0Pharmacol Exp Ther 326(1):89\u201399","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"820_CR10","doi-asserted-by":"publisher","first-page":"427","DOI":"10.15252\/embj.201796692","volume":"37","author":"AH Kanellopoulos","year":"2018","unstructured":"Kanellopoulos\u00a0AH, Koenig\u00a0J, Huang\u00a0H, Pyrski\u00a0M, Millet\u00a0Q, Lolignier\u00a0S, Morohashi\u00a0T, Gossage\u00a0SJ, Jay\u00a0M, Linley\u00a0JE, Baskozos\u00a0G, Kessler\u00a0BM, Cox\u00a0JJ, Dolphin\u00a0AC, Zufall\u00a0F, Wood\u00a0JN, Zhao\u00a0J (2018) Mapping protein interactions of sodium channel Na(V)1.7 using epitope-tagged gene-targeted mice. Embo\u00a0J 37(3):427\u2013445","journal-title":"Embo J"},{"issue":"7","key":"820_CR11","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1097\/j.pain.0000000000000555","volume":"157","author":"A Moutal","year":"2016","unstructured":"Moutal\u00a0A, Chew\u00a0LA, Yang\u00a0X, Wang\u00a0Y, Yeon\u00a0SK, Telemi\u00a0E, Meroueh\u00a0S, Park\u00a0KD, Shrinivasan\u00a0R, Gilbraith\u00a0KB, Qu\u00a0C, Xie\u00a0JY, Patwardhan\u00a0A, Vanderah\u00a0TW, Khanna\u00a0M, Porreca\u00a0F, Khanna\u00a0R (2016) (S)-lacosamide inhibition of CRMP2 phosphorylation reduces postoperative and neuropathic pain behaviors through distinct classes of sensory neurons identified by constellation pharmacology. Pain 157(7):1448\u20131463","journal-title":"Pain"},{"issue":"7","key":"820_CR12","first-page":"289","volume":"59","author":"JM Gomez-Arguelles","year":"2014","unstructured":"Gomez-Arguelles\u00a0JM, Bermejo\u00a0PE, Lara\u00a0M, Almajano\u00a0J, Aragon\u00a0E (2014) F.\u00a0Garcia del Carrizo, M.V.\u00a0Blanco, F.J.\u00a0Valenzuela-Rojas, J.\u00a0Colas, O.\u00a0Sanchez-Del Valle, M.\u202fA.\u00a0Ceballos, M.\u202fE.\u00a0Toribio-Diaz, G.\u00a0Latorre-Gonzalez, L.\u00a0Costa-Frossard, and M.\u00a0Morin-Martin Mdel, [Effectiveness of lacosamide in the treatment of refractory neuropathic pain: an open observational trial. Rev Neurol 59(7):289\u2013293","journal-title":"Rev Neurol"},{"key":"820_CR13","doi-asserted-by":"crossref","unstructured":"Elgamal S, Ahmed SR, Nahas MM, Hendawy SR, Elshafei O, Zeinhom MG (2024) The effect of lacosamide on calcitonin gene-related peptide serum level in episodic migraine patients: a\u00a0randomized, controlled trial. Acta Neurol Belg","DOI":"10.1007\/s13760-024-02499-9"},{"issue":"4","key":"820_CR14","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1111\/head.14505","volume":"63","author":"A Munoz-Vendrell","year":"2023","unstructured":"Munoz-Vendrell\u00a0A, Tena-Cucala\u00a0R, Campoy\u00a0S, Garcia-Parra\u00a0B, Prat\u00a0J, Martinez-Yelamos\u00a0S, Huerta-Villanueva\u00a0M (2023) Oral lacosamide for the treatment of refractory trigeminal neuralgia: A\u00a0retrospective analysis of 86\u00a0cases. Headache 63(4):559\u2013564","journal-title":"Headache"},{"issue":"10","key":"820_CR15","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1177\/03331024221092435","volume":"42","author":"A Munoz-Vendrell","year":"2022","unstructured":"Munoz-Vendrell\u00a0A, Teixidor\u00a0S, Sala-Padro\u00a0J, Campoy\u00a0S, Huerta-Villanueva\u00a0M (2022) Intravenous lacosamide and phenytoin for the treatment of acute exacerbations of trigeminal neuralgia: A\u00a0retrospective analysis of 144 cases. Cephalalgia 42(10):1031\u20131038","journal-title":"Cephalalgia"},{"key":"820_CR16","doi-asserted-by":"crossref","unstructured":"Kucic N, Racki V, Sverko R, Vidovic T, Grahovac I, Mrsic-Pelcic J (2021) Immunometabolic Modulatory Role of Naltrexone in BV\u20112 Microglia Cells. Int J Mol Sci 22(16)","DOI":"10.3390\/ijms22168429"},{"issue":"10","key":"820_CR17","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s11916-020-00898-0","volume":"24","author":"PS Kim","year":"2020","unstructured":"Kim\u00a0PS, Fishman\u00a0MA (2020) Low-Dose Naltrexone for Chronic Pain: Update and Systemic Review. Curr Pain Headache Rep 24(10):64","journal-title":"Curr Pain Headache Rep"},{"issue":"2","key":"820_CR18","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1002\/art.37734","volume":"65","author":"J Younger","year":"2013","unstructured":"Younger\u00a0J, Noor\u00a0N, McCue\u00a0R, Mackey\u00a0S (2013) Low-dose naltrexone for the treatment of fibromyalgia: findings of a\u00a0small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels. Arthritis Rheum 65(2):529\u2013538","journal-title":"Arthritis Rheum"}],"container-title":["Der Schmerz"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00482-024-00820-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00482-024-00820-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00482-024-00820-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T07:04:48Z","timestamp":1727075088000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00482-024-00820-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,14]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["820"],"URL":"https:\/\/doi.org\/10.1007\/s00482-024-00820-2","relation":{},"ISSN":["0932-433X","1432-2129"],"issn-type":[{"type":"print","value":"0932-433X"},{"type":"electronic","value":"1432-2129"}],"subject":[],"published":{"date-parts":[[2024,8,14]]},"assertion":[{"value":"14 June 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"W.\u00a0Liedtke ist Vollzeit in leitender Funktion angestellt bei Regeneron Pharmaceuticals, Tarrytown, NY, USA, was den Inhalt dieses Leserbriefs nicht beeinflusst. Der Artikel stellt die eigene Meinung und eigenst\u00e4ndige Position des Autors dar, nicht die von Regeneron, ebenfalls nicht die der Duke University, New York University oder US Facial Pain Association.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}